Tyler-Stone Wealth Management’s Gilead Sciences GILD Stock Holding History

Tyler-Stone Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-9	Closed	-$1.71K	–	550
2024 Q2	$1.71K	Sell	9 -4	-31%	-$267	﹤0.01%	867
2024 Q1	$4.64K	Sell	13 -8	-38%	-$615	﹤0.01%	766
2023 Q4	$9.87K	Buy	21 +10	+91%	+$778	﹤0.01%	640
2023 Q3	$1K	Sell	11 -8	-42%	-$615	﹤0.01%	852
2023 Q2	$2K	Buy	+19	New	+$1.51K	﹤0.01%	799
2022 Q4	$11K	Buy	+19	New	+$1.5K	0.01%	537
2022 Q1	–	Sell	-3	Closed	-$2K	–	877
2021 Q4	$2K	Buy	+3	New	+$207	﹤0.01%	797

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tyler-Stone Wealth Management's GILD Position: Q2 2025 in Review

Tyler-Stone Wealth Management reduced its Gilead Sciences (GILD) stake by 3.6% in Q2 2025, selling an estimated $21.3K and leaving 5,294 shares worth $587K. The position accounts for 0.09% of the portfolio, ranked #184.

Tyler-Stone Wealth Management first reported a position in GILD in Q4 2021 and has held it in 14 quarters since. The position peaked at $616K in Q1 2025. 2,024 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

Tyler-Stone Wealth Management held 5,294 shares of Gilead Sciences worth $587K as of Q2 2025.
Tyler-Stone Wealth Management sold 200 Gilead Sciences shares in Q2 2025, an estimated $21.3K.
Gilead Sciences made up 0.09% of Tyler-Stone Wealth Management's portfolio in Q2 2025, its #184 holding.
Tyler-Stone Wealth Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 14 quarters since.
Tyler-Stone Wealth Management's Gilead Sciences position peaked at $616K in Q1 2025.
2,024 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Tyler-Stone Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.